Skip to main content
. 2021 May 1;40:151. doi: 10.1186/s13046-021-01957-z

Fig. 1.

Fig. 1

Lnc-CTSLP8 was upregulated in ovarian cancer. a, b TCGA data analysis of lnc-CTSLP8 expression in samples from ovarian cancer patients with different disease stages (a) and grades (b). c qRT-PCR of lnc-CTSLP8 expression in benign ovarian cyst tissues (used as control), ovarian cancer tissues, and matched peritoneal metastasis tissues. d qRT-PCR of lnc-CTSLP8 expression in different ovarian cancer cell lines. e qRT-PCR of lnc-CTSLP8 in CTSLP8 overexpression cell lines (SKOV3-CTSLP8-OE and OVCA420-CTSLP8-OE), the lnc-CTSLP8 knockout cell line (Hey-CTSLP8-KO), negative control cell lines (control vector), and wild-type (WT) cell lines. Data are shown as the mean ± SEM